EVeium increases localisation to make premium e-scooters more affordable
, an electric two-wheeler brand under Ellysium Automotives, has announced a move to increase the localisation of its components in an effort to make its premium electric scooters more affordable in the Indian market.
The company is expanding its domestic manufacturing capabilities to reduce production costs and improve accessibility. This approach supports the broader national goal of self-reliance in clean mobility and enables tighter control over quality and faster development cycles.
Focus on domestic production
EVeium's key models—Cosmo, Comet, and Czar—are being reintroduced with updated features and new styling. With a larger share of the manufacturing ecosystem now based in India, the company said it is able to offer its vehicles at more competitive price points.
"At EVeium, we've always believed that sustainable mobility shouldn't come at the cost of accessibility," said Sameer Moidin, Founder & CEO, EVeium Smart Mobility. "By increasing the localisation of our components and reinforcing our manufacturing ecosystem in India, we are now able to offer electric scooters at prices that resonate with the Indian market."
The company's move to deepen domestic sourcing and production is aimed at strengthening its position in India's electric mobility sector and supporting long-term growth in the two-wheeler segment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
3 minutes ago
- Hindustan Times
OpenAI staffer baffled by Indian airport security: ‘Why check bags after X-ray?'
An OpenAI employee, currently on a trip to India, has raised some pertinent questions about the security checks and procedures at Indian airports. In a now-viral X post, Will DePue asked why his bag needed to be checked manually after it had already been X-rayed. He pointed out that the multiple — and often needless — security checks hold up long queues of passengers and cause unnecessary delays. An American techie questions repeated security checks at Indian airports (X/@SparshAgarwall) San Francisco-based DePue listed the many security checks that all passengers must undergo at any given airport in India. 'Indian airports make no sense' 'Indian airports make no sense,' the OpenAI employee wrote, before listing the security checks. He said that a passenger cannot enter the airport without a passport and receipt check, a physical pat-down, and a metal scan. After walking into the airport, everyone is subjected to a pre-security boarding pass and passport check. Before getting to the security checkpoint, the boarding pass and passport is checked again, said DePue. Then, everybody's carry-on bags are passed through an X-ray machine, while passengers themselves are 'patted down and wanded.' Before passengers can board the plane, their boarding passes are checked again. At this point, one would think this is the end of all security checks – but no. DePue ranted that his bags were checked manually before he could enter the plane. He questioned the logic of checking bags manually after they had just passed through an X-ray scanner. 'BUT I JUST GOT X RAYED. WHAT ARE YOU GOING TO FIND NOW? there's a giant line of people waiting to get to the plane,' he wrote. Who is Will DePue? Will DePue is an OpenAI employee based in San Francisco. His LinkedIn profile lists him as a 'Member of the Technical Staff' at OpenAI, where he was a core contributor to Sora, the company's first text-to-video model. DePue is part of a group trip to India curated specifically for techies and builders. The Discovery of India trip is meant to give curious techies a first-hand look at modern India and how its technology, policy, culture, and history come together to shape the future.
Mint
3 minutes ago
- Mint
Indian chemical stocks are still the FPI darlings. Will they withstand the US tariff heat?
The chemicals and petrochemicals sector has been the biggest draw for foreign money in Indian equities in the last 11 months. It is the only industry to clock uninterrupted foreign portfolio investment (FPI) inflows, even as other sectors saw choppy trends during this period. In July 2025, overseas investors pumped in $130 million into Indian chemical and petrochemical stocks, following a hefty $278 million in June, showed data from NSDL. A year ago, FPIs had pulled out net equity investment worth $61 million from the sector. The telecom equipment space topped the charts for FPI inflows in July, attracting $570 million in net equity investment, followed by metals and mining with $388 million, and food, beverages and tobacco at $175 million. While the chemicals and petrochemicals sector saw 11 consecutive months of FPI buying, the telecom sector witnessed a steady inflow of foreign money since December. Metals and mining, along with food, beverages, and tobacco, attracted foreign inflows only in July. According to NSDL, FPIs were net sellers in the Indian equity markets in July, with a total outflow of ₹17,741 crore. Investors in chemical companies have been rewarded handsomely. In the year to 12 August, dye maker Indochem topped the list, delivering 308% gains, while specialty chemicals producer Camlin Fine Sciences gave 115%. Pigment manufacturer Kesar Petroproducts (63%), aroma and fragrance maker Privi Specialty Chemicals (59%), and life sciences-focused Anupam Rasayan (52%) also posted stellar returns. However, in the last one month, most chemical stocks have come under pressure because of US President Donald Trump's tariffs. Hikal slipped 20%, while Castrol India and Laxmi Organic eased 4%, Fine Organic and Gujarat Alkalies fell 5%, and Alkyl Amines, Archean Chemical, and Deepak Nitrite were down 7% each. Linde India dropped 8.5%, Atul 10.5%, and Fairchem Organic 12.5%. Losses were steeper for Aarti Surfactants, Aarti Industries, and Vinati Organics at 15% each, Clean Science at 17%, and Camlin Fine Sciences, plunged 24%. A few names, however, swam against the tide: Bliss GVS Pharma gained 13%, Tatva Chintan rose 9%, Tata Chemicals added 5%, Sudarshan Chemical climbed 19%, and TGV Sraac surged an impressive 32%. Now the key question facing investors is whether the momentum in chemical and petrochemical stocks can hold up after US President Donald Trump announced an additional 25% tariff on India, taking the total hit to a hefty 50%. According to the Indian Trade Portal, India is the sixth-largest chemical producer in the world and the third-largest in Asia. It ranks 14th in global chemical exports (excluding pharmaceuticals), contributing 2.5% to global chemical sales. Ratings firm Icra, in its August report, said 60% of India's agrochemicals output is exported, with the US accounting for 18% in FY2025. The US also sources agrochemicals heavily from the EU, Mexico, and China; while the EU now faces a 15% tariff, Mexico's rates match India's, and China continues to face 30%. India is a key US supplier of dyes, pigments, and other chemicals alongside China, the EU, and Mexico. However, tariff advantages for the EU and narrowing gaps with China could increase pricing pressure on Indian exports. The hope that pharma and healthcare might escape US tariffs had sparked some cheer, spilling over into a rally for chemicals and petrochemicals earlier this year, said Nilesh Ghuge, research analyst at HDFC Securities. But that optimism may be short-lived if Trump goes ahead with extra tariffs, he warned. 'Until there's clarity, investors might be better off sitting on the sidelines rather than jumping in head-first." Ghuge sees volumes inching up but says prices may take another couple of quarters to recover. Research co-head at PL Capital, Swarnendu Bhushan, also remains cautious on the sector and does not see a rebound anytime soon. 'Margins are shrinking, volumes are inching up, but prices aren't recovering, with Chinese overcapacity dumping extra supply into the market," he said. Also Read: China has now disrupted specialty chemical market. Startups step up Tariffs could shave off some exports, especially of more commoditised products, said Prashant Vasisht, senior vice president and co-group head, corporate ratings, Icra. Commodity chemicals are high-volume, standardized products—like sulfuric acid or ethylene—made for global and domestic markets. They serve as basic raw materials for other industries and show little difference from one producer to another. "However, certain speciality chemicals could bear the brunt of tariffs and still maintain volumes," he added. Pricey or fair deal? 'Valuations remain lofty for most chemical and petrochemical names, especially with Chinese dumping squeezing margins, but there are still a few decently priced pockets that could quietly deliver alpha," said Ghuge of HDFC Securities. Valuations are well above their five-year averages. Tatva Chintan, for instance, is trading at a sky-high price-to-earnings (P/E) of 615.67 versus its five-year average of 477.37. Tata Chemicals (42.6 from 31.48), Gujarat Fluorochemicals (58.02 vs 44.16), Deepak Fertilisers and Petrochemicals (43.52 vs 30.72), Archean Chemical (34.98 vs 25.67), SRF (60.30 vs 47.88), and Aarti Industries (55.50 vs 41.61) are also sporting richer-than-usual multiples. Market participants point to massive capacity additions in China and a weak global economic outlook as key headwinds, while the positives lie in a healthy domestic demand outlook and a gradual shift in global supply chains towards India. Also Read: Why Coromandel International has thrived while many fertilizer companies have struggled Scope for upgrades Ambit Asset Management's July newsletter noted that after the boom years of FY20–22, the market expected strong growth for FY22–25, projecting a 23% earnings CAGR and 25% median Ebitda margin. Instead, revenue fell at a -3% CAGR and margins dropped to 13% in FY24, before recovering to 18% in the second half of FY25 as businesses stabilised. Looking ahead, after the weak FY22-25 period, the market now expects only a modest recovery—18% revenue CAGR over FY25–27, with average Ebitda margins improving slightly to 18% in FY27 from 16% in FY25. 'We believe there is significant scope of upgrades to these assumptions given global channel inventory is at a 5-year low, which suggests restocking led demand; recent pricing up-move indicates strong improvement in margins as well, and resultantly, we believe there is scope for upgrades," said Ambit Asset. Also Read: India eases quality control norms on key chemicals imported from the US, China
Mint
3 minutes ago
- Mint
India falls from top to least favoured Asian stock market in 3 months amid Trump's tariff concerns: BofA Survey
(Bloomberg) -- India has gone from fund managers' top Asian stock market pick to their least preferred in just three months amid US President Donald Trump's tariff escalation, according to a Bank of America Corp. survey. In the most recent fund manager survey, 30% said they are underweight on India, followed by 20% for Thailand and 10% for Malaysia. Japan fared the best, with China taking the No. 2 spot. A total of 99 panelists with $183 billion of assets responded to the survey's regional questions. That marks a sharp reversal from May's survey, which showed India displacing Japan as the most favored market due to its perceived haven status during Trump's initial tariff rollout. The change in sentiment for the $5.2 trillion equity market underscores growing investor concern about Trump's decision to double levies on the South Asian country's goods as a penalty for its purchases of Russian oil. 'India is affected by President Trump's announcement of 50% tariffs,' strategists including Ritesh Samadhiya wrote in a Aug. 12 note. That contrasts with other markets in the region including China, where the tone has 'become more enthusiastic.' Trade angst, weak earnings and expensive valuations have prompted global funds to withdraw about $4 billion from Indian shares this quarter, though domestic institutions and retail investors have ramped up purchases. The nation's stocks-focused mutual funds, which get the bulk of their flows from individual traders, pulled in a record 427 billion rupees ($4.9 billion) on a net basis in July, data from the Association of Mutual Funds in India showed. Still, Indian stocks registered their worst weekly losing streak since the onset of the Covid-19 pandemic last week, and have lagged major Asian peers this year. Chinese shares outperformed their Indian counterparts by about eight percentage points in July — the most since February. 'Trump's harsh tariffs and the straining of relations between US and India have impacted market sentiment,' said V K Vijayakumar, chief investment strategist at Geojit Investments. Tepid earnings growth and elevated valuations have 'emboldened the bears to increase the short positions,' he said.
